Bar Admissions

  • New York

Court Admissions

  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Western District of New York
  • U.S. Supreme Court


  • J.D., Franklin Pierce Law Center, 1990
  • B.S., Mechanical Engineering, Rensselaer Polytechnic Institute, 1982
T +1 212.218.2204
F +1 212.218.2200

Dominick A. Conde


Dom Conde is co-chair of Venable's Intellectual Property Division. The competitive spirit that Dom Conde brings to every one of his engagements has made him one of the nation's preeminent patent litigators. For more than 25 years, it has fueled his work on large-scale patent litigation, in which he often represents pharmaceutical clients in high-value ANDA matters. Those familiar with his work call him a "top pharma lawyer" and say that he "completely stands out in terms of raw intelligence, lawyering skills and putting together the perfect case." – Chambers USA

In addition to serving as lead counsel in Hatch-Waxman litigation, Dom regularly represents clients in contested proceedings before the U.S. Patent and Trademark Office. He also frequently represents clients outside the pharmaceutical industry.

The consistent thread in all of Dom's work – and the reason he is regularly recognized as one of the top IP litigators in the country – is his indefatigable will to reach a favorable result for his client. It's why he is known not only as an "intellectual giant" – Best Lawyers, but as a "mature, pragmatic lawyer with great judgment." – IAM 250

Before joining Venable, Dom spent his career in private practice at Fitzpatrick, Cella, Harper & Scinto.

Representative Clients

  • Astellas
  • Pernix
  • Reckitt Benckiser
  • Sanofi

Significant Matters

  • Astellas, Pfizer, and U. of California against Actavis, Zydus, Roxane and Apotex on patents covering Xtandi® used for the treatment of prostate cancer.
  • Aralez Pharmaceuticals against Actavis on patents covering Yosprala® used for the prevention of cardiovascular events for patients that are at risk of developing gastric ulcers.
  • Pernix Therapeutics against Alvogen and Actavis on patents covering Zohydro® used to relief severe pain.
  • Sanofi-Aventis against Fresenius, Accord Healthcare, Mylan and Actavis on patents covering Jevtana® used to treat metastatic prostate cancer.
  • Pozen Inc. against Actavis, Dr. Reddy’s Laboratories, Mylan and Lupin on patents covering Vimovo® used by patients that have arthritis pain and risk of NSAID induced stomach ulcers.
  • Novartis Pharmaceuticals Corp. against Noven Pharmaceuticals on patents covering Exelon® Patch (rivastigmine) used to treat Alzheimer’s disease.
  • Warner Chilcott against Teva Pharmaceuticals and Watson Laboratories on patents covering Atelvia® used for the treatment of osteoporosis.
  • Warner Chilcott against Mylan Pharamceuticals and Lupin on a patent covering Generess® for oral contraception.
  • Warner Chilcott against Lupin and Watson Laboratories on patents covering Lo Loestrin 24®, a low dose oral contraceptive.
  • Warner Chilcott against Watson Laboratories on a patent covering Loestrin 24®, an oral contraceptive. Reliable Sprinkler Co. against a complaint filed by Tyco Fire Products on multiple patents relating to fire protection sprinklers.
  • Sanofi-Aventis against Sandoz Inc., et al. on a patent relating to Eloxatin® a treatment option for stage III colon cancer and advanced colorectal cancer.
  • Warner Chilcott against multiple defendants on a patent relating to Doryx®, a broad-spectrum tetracycline antibiotic.
  • Warner Chilcott against Barr Laboratories and Watson Pharmaceuticals on patents relating to Warner Chilcott's Femcon Fe® chewable oral contraceptive.
    Entegris against infringement allegations relating to filtration technology.
  • Reckitt Benckiser against Tris Pharmaceuticals and Amneal Pharmaceuticals concerning patents relating to Delsum®, a 12-hour cough suppressant.
  • Sepracor Pharmaceuticals against Sandoz Inc., et al. on patents relating to Clarinex®, an allergy medication.
  • Adams Respiratory against multiple defendants on patents relating to Adams' highly successful Mucinex® product.
  • KOS Pharmaceuticals against Barr Laboratories on patents covering KOS’ niaspan anti-cholesterol drugs.
  • Bristol Myers against Teva Pharmaceuticals regarding patents covering Bristol’s anti-bacterial agent gatifloxacin.
  • Warner Chilcott against KV Pharmaceuticals on a patent covering pregnancy vitamins.
  • Bristol-Myers against Rhone-Poulenc Rorer on patents relating to semi-synthetic process technology for making Taxol.
  • Dixon Ticonderoga against Dri Mark Products in patents involving metallic inks used in writing instruments.
  • American Maize Products against Grain Processing Corp. on patents relating to maltodextrin food additives.
  • Bausch & Lomb against Alcon Laboratories on technology regarding contact lens disinfectants.
  • Exxon against Lubrizol regarding motor oil additives.